Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Read article at bloomberg.com
Saturday, August 09, 2008
Lilly trained its sales force to downplay Zyprexa's risks
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";